EXHIBIT 99.2
Report of Voting Results
Medicenna Therapeutics Corp.
In accordance with Section 11.3 of National Instrument 51-102, the following describes the matters voted upon and the outcome of the votes at the annual and special meeting of shareholders of Medicenna Therapeutics Corp. (the “Corporation”) held on September 30, 2020 in Toronto, Ontario.
1. | By a show of hands, each of the nominees for election as directors were elected to hold office until the next annual meeting of shareholders or until such director resigns or a successor is elected or appointed. |
Proxies received and represented at the meeting were as follows:
Nominee | Votes For | % of Votes For | Votes Withheld | % of Votes Withheld |
Dr. Fahar Merchant | 22,306,905 | 99.680 | 71,600 | 0.320 |
Mr. Albert Beraldo | 22,373,805 | 99.979 | 4,700 | 0.021 |
Ms. Karen Dawes | 22,373,805 | 99.979 | 4,700 | 0.021 |
Dr. John (Jack) Geltosky | 22,358,152 | 99.909 | 20,353 | 0.091 |
Ms. Rosemina Merchant | 22,295,252 | 99.628 | 83,253 | 0.372 |
Dr. Chandrakant Panchal | 22,306,885 | 99.680 | 71,620 | 0.320 |
2. | By a show of hands, PricewaterhouseCoopers LLP was appointed as auditor of the Corporation to hold office until the next annual meeting or until its successor is appointed, and the directors were authorized to fix its remuneration. Approximately 99.90% of the proxies received and represented at the meeting were voted in favour of the appointment and approximately 0.10% of the proxies received and represented at the meeting were withheld from voting. |
3. | By a show of hands, the resolution approving By-Law No. 2 was passed as proposed. Approximately 97.959% of the proxies received and represented at the meeting were voted in favour of the resolution and approximately 2.041% of the proxies received and represented at the meeting were voted against the resolution. |
4. | By a show of hands, the resolution approving all unallocated options under the stock option plan of the Corporation was passed as proposed. Approximately 97.321% of the proxies received and represented at the meeting were voted in favour of the resolution and approximately 2.679% of the proxies received and represented at the meeting were voted against the resolution. |
In total, approximately 61.56% of the issued and outstanding shares were represented in person or by proxy at the meeting.
Yours very truly,
/s/ Elizabeth Williams
Elizabeth Williams
Chief Financial Officer